SC
WST icon

Syon Capital’s West Pharmaceutical WST Stock Holding History

Syon Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$876K Buy
2,439
+719
+42% +$220K 0.04% 403
2026
Q1 		$431K Sell
1,720
-57
-3% -$14.2K 0.02% 612
2025
Q4 		$489K Buy
1,777
+19
+1% +$5.2K 0.02% 569
2025
Q3 		$461K Buy
1,758
+767
+77% +$186K 0.02% 521
2025
Q2 		$217K Buy
+991
New +$212K 0.01% 668
2024
Q2 		– Sell
-712
Closed -$282K – 463
2024
Q1 		$282K Buy
+712
New +$263K 0.03% 375

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Syon Capital's WST Position: Q2 2026 in Review

Syon Capital increased its West Pharmaceutical (WST) stake by 42% in Q2 2026, buying an estimated $220K and bringing the position to 2,439 shares worth $876K. The position accounts for 0.04% of the portfolio, ranked #403.

Syon Capital first reported a position in WST in Q1 2024 and has held it in 6 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Syon Capital held 2,439 shares of West Pharmaceutical worth $876K as of Q2 2026.
  • Syon Capital bought 719 West Pharmaceutical shares in Q2 2026, an estimated $220K.
  • West Pharmaceutical made up 0.04% of Syon Capital's portfolio in Q2 2026, its #403 holding.
  • Syon Capital first reported a position in West Pharmaceutical in Q1 2024 and has held it in 6 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.